Direxion S&P Biotech Bull 3X ETF (LABU)

[value1008]

I thought that news last night of that Senate-passed Cures Act would have zoomed the sector up this a.m. but evidently the expected passing of the legislation was already "baked in," given the almost unanimous support for the bill, hence the lack of a big positive upmove.

Well, at least LABU closed in the green and it looks like it could again challenge resistance up at its 50dma within the next few days, and maybe leap above it again.